TRENDS CARDIOVAS MED 润色咨询

TRENDS IN CARDIOVASCULAR MEDICINE

出版年份:1991 年文章数:439 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:4.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2152940, encodeId=0f0021529400d, content=请问在线发表多久后可以在WOS上查到?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Tue Aug 15 22:24:49 CST 2023, time=2023-08-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1098150, encodeId=e26e10981505e, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098149, encodeId=1d651098149bb, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579941, encodeId=a93b5e9941f6, content=需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533602, encodeId=171d533602d5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:绝大部分都是综述类文章,还不是大综述,多是编辑评述这一类小综述,文章很短,2页左右,多是约稿而来。另外,这个杂志很特别,可以收一类叫My Approach的文章,也多是约稿的。自己这样介绍:Trends in Cardiovascular Medicine provides in depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:30:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504582, encodeId=fa40504582c9, content=惊喜,去年只有1分多一点,今年一下子到2分多,不过上3分,就相当于过门槛了,接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481564, encodeId=7547481564b6, content=明年会不会再跌呀,万一跌破怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480681, encodeId=685e48068103, content=明年会不会降到3分呀,如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2023-08-15 若曦jennifer 来自辽宁省

    请问在线发表多久后可以在WOS上查到?谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2152940, encodeId=0f0021529400d, content=请问在线发表多久后可以在WOS上查到?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Tue Aug 15 22:24:49 CST 2023, time=2023-08-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1098150, encodeId=e26e10981505e, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098149, encodeId=1d651098149bb, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579941, encodeId=a93b5e9941f6, content=需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533602, encodeId=171d533602d5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:绝大部分都是综述类文章,还不是大综述,多是编辑评述这一类小综述,文章很短,2页左右,多是约稿而来。另外,这个杂志很特别,可以收一类叫My Approach的文章,也多是约稿的。自己这样介绍:Trends in Cardiovascular Medicine provides in depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:30:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504582, encodeId=fa40504582c9, content=惊喜,去年只有1分多一点,今年一下子到2分多,不过上3分,就相当于过门槛了,接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481564, encodeId=7547481564b6, content=明年会不会再跌呀,万一跌破怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480681, encodeId=685e48068103, content=明年会不会降到3分呀,如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    期刊可以有几个通讯作者/第一作者?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2152940, encodeId=0f0021529400d, content=请问在线发表多久后可以在WOS上查到?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Tue Aug 15 22:24:49 CST 2023, time=2023-08-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1098150, encodeId=e26e10981505e, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098149, encodeId=1d651098149bb, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579941, encodeId=a93b5e9941f6, content=需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533602, encodeId=171d533602d5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:绝大部分都是综述类文章,还不是大综述,多是编辑评述这一类小综述,文章很短,2页左右,多是约稿而来。另外,这个杂志很特别,可以收一类叫My Approach的文章,也多是约稿的。自己这样介绍:Trends in Cardiovascular Medicine provides in depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:30:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504582, encodeId=fa40504582c9, content=惊喜,去年只有1分多一点,今年一下子到2分多,不过上3分,就相当于过门槛了,接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481564, encodeId=7547481564b6, content=明年会不会再跌呀,万一跌破怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480681, encodeId=685e48068103, content=明年会不会降到3分呀,如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    什么是correspondingauthor/通讯作者?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2152940, encodeId=0f0021529400d, content=请问在线发表多久后可以在WOS上查到?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Tue Aug 15 22:24:49 CST 2023, time=2023-08-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1098150, encodeId=e26e10981505e, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098149, encodeId=1d651098149bb, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579941, encodeId=a93b5e9941f6, content=需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533602, encodeId=171d533602d5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:绝大部分都是综述类文章,还不是大综述,多是编辑评述这一类小综述,文章很短,2页左右,多是约稿而来。另外,这个杂志很特别,可以收一类叫My Approach的文章,也多是约稿的。自己这样介绍:Trends in Cardiovascular Medicine provides in depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:30:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504582, encodeId=fa40504582c9, content=惊喜,去年只有1分多一点,今年一下子到2分多,不过上3分,就相当于过门槛了,接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481564, encodeId=7547481564b6, content=明年会不会再跌呀,万一跌破怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480681, encodeId=685e48068103, content=明年会不会降到3分呀,如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2019-11-16 努力的科研小白

    需要版面费吗?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2152940, encodeId=0f0021529400d, content=请问在线发表多久后可以在WOS上查到?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Tue Aug 15 22:24:49 CST 2023, time=2023-08-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1098150, encodeId=e26e10981505e, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098149, encodeId=1d651098149bb, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579941, encodeId=a93b5e9941f6, content=需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533602, encodeId=171d533602d5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:绝大部分都是综述类文章,还不是大综述,多是编辑评述这一类小综述,文章很短,2页左右,多是约稿而来。另外,这个杂志很特别,可以收一类叫My Approach的文章,也多是约稿的。自己这样介绍:Trends in Cardiovascular Medicine provides in depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:30:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504582, encodeId=fa40504582c9, content=惊喜,去年只有1分多一点,今年一下子到2分多,不过上3分,就相当于过门槛了,接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481564, encodeId=7547481564b6, content=明年会不会再跌呀,万一跌破怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480681, encodeId=685e48068103, content=明年会不会降到3分呀,如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2017-03-02 lovetcm

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:绝大部分都是综述类文章,还不是大综述,多是编辑评述这一类小综述,文章很短,2页左右,多是约稿而来。另外,这个杂志很特别,可以收一类叫My Approach的文章,也多是约稿的。自己这样介绍:Trends in Cardiovascular Medicine provides in depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies.

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2152940, encodeId=0f0021529400d, content=请问在线发表多久后可以在WOS上查到?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Tue Aug 15 22:24:49 CST 2023, time=2023-08-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1098150, encodeId=e26e10981505e, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098149, encodeId=1d651098149bb, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579941, encodeId=a93b5e9941f6, content=需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533602, encodeId=171d533602d5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:绝大部分都是综述类文章,还不是大综述,多是编辑评述这一类小综述,文章很短,2页左右,多是约稿而来。另外,这个杂志很特别,可以收一类叫My Approach的文章,也多是约稿的。自己这样介绍:Trends in Cardiovascular Medicine provides in depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:30:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504582, encodeId=fa40504582c9, content=惊喜,去年只有1分多一点,今年一下子到2分多,不过上3分,就相当于过门槛了,接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481564, encodeId=7547481564b6, content=明年会不会再跌呀,万一跌破怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480681, encodeId=685e48068103, content=明年会不会降到3分呀,如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2014-07-30 zhiqi

    惊喜,去年只有1分多一点,今年一下子到2分多,不过上3分,就相当于过门槛了,接下为就容易了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2152940, encodeId=0f0021529400d, content=请问在线发表多久后可以在WOS上查到?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Tue Aug 15 22:24:49 CST 2023, time=2023-08-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1098150, encodeId=e26e10981505e, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098149, encodeId=1d651098149bb, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579941, encodeId=a93b5e9941f6, content=需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533602, encodeId=171d533602d5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:绝大部分都是综述类文章,还不是大综述,多是编辑评述这一类小综述,文章很短,2页左右,多是约稿而来。另外,这个杂志很特别,可以收一类叫My Approach的文章,也多是约稿的。自己这样介绍:Trends in Cardiovascular Medicine provides in depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:30:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504582, encodeId=fa40504582c9, content=惊喜,去年只有1分多一点,今年一下子到2分多,不过上3分,就相当于过门槛了,接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481564, encodeId=7547481564b6, content=明年会不会再跌呀,万一跌破怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480681, encodeId=685e48068103, content=明年会不会降到3分呀,如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 med—doctor

    明年会不会再跌呀,万一跌破怎么办?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2152940, encodeId=0f0021529400d, content=请问在线发表多久后可以在WOS上查到?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Tue Aug 15 22:24:49 CST 2023, time=2023-08-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1098150, encodeId=e26e10981505e, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098149, encodeId=1d651098149bb, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579941, encodeId=a93b5e9941f6, content=需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533602, encodeId=171d533602d5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:绝大部分都是综述类文章,还不是大综述,多是编辑评述这一类小综述,文章很短,2页左右,多是约稿而来。另外,这个杂志很特别,可以收一类叫My Approach的文章,也多是约稿的。自己这样介绍:Trends in Cardiovascular Medicine provides in depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:30:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504582, encodeId=fa40504582c9, content=惊喜,去年只有1分多一点,今年一下子到2分多,不过上3分,就相当于过门槛了,接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481564, encodeId=7547481564b6, content=明年会不会再跌呀,万一跌破怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480681, encodeId=685e48068103, content=明年会不会降到3分呀,如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=531, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 bio_mini

    明年会不会降到3分呀,如果降3分以下就不值了

    0

共10条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分